tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jessica Fye, 90 are a HOLD (35.57%), 135 are a BUY (53.36%), 28 are a SELL (11.07%).
Analyst Jessica Fye, currently employed at JPMORGAN, carries an average stock price target met ratio of 78.8% that have a potential upside of 23.22% achieved within 151 days.
Jessica Fye’s has documented 490 price targets and ratings displayed on 47 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 24-Mar-2025.
Analyst best performing recommendations are on STOK (STOKE THERAPEUTICS).
The best stock recommendation documented was for STOK (STOKE THERAPEUTICS) at 3/26/2024. The price target of $13 was fulfilled within 1 day with a profit of $2.71 (26.34%) receiving and performance score of 263.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
1 years 4 months 11 days ago
(20-Nov-2023)
1/3 (33.33%)
$-0.04 (-0.99%)
300
Hold
$1
$-0.07 (-6.54%)
$5
1 years 5 months 6 days ago
(25-Oct-2023)
4/21 (19.05%)
$0.29 (40.85%)
32
Sell
$1
$-0.07 (-6.54%)
$3.5
1 years 8 months 12 days ago
(19-Jul-2023)
8/11 (72.73%)
$-0.08 (-7.41%)
55
Hold
$1.25
$0.18 (16.82%)
$2
1 years 8 months 12 days ago
(19-Jul-2023)
2/5 (40%)
$0.17 (15.74%)
215
Buy
$10
2 years 9 months 9 days ago
(22-Jun-2022)
13/47 (27.66%)
$6.81 (213.48%)
194
Which stock is Jessica Fye is most bullish on?
Which stock is Jessica Fye is most reserved on?
What Year was the first public recommendation made by Jessica Fye?
